NEURELIS JOINS THE EPILEPSY COMMUNITY AT ANNUAL SOFIE’S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND® RESORT
Company’s Ambassadors to share their experiences and connect with epilepsy community SAN DIEGO, CA – November 16, 2026 – Neurelis, Inc., a neuroscience company and innovator behind VALTOCO® (diazepam nasal spray), announced today it will participate in the 14th Annual Sofie’s Journey Epilepsy Awareness Day & Education Expo at Disneyland (EADDL). The Company will […]